Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview

Area of Science:

• Gastroenterology
• Internal Medicine
• Clinical Nutrition

Background:

• Malnutrition and sarcopenia (reduced muscle mass and strength) are common in inflammatory bowel disease (IBD).
• Sarcopenia prevalence in Crohn's disease and ulcerative colitis is estimated at 52% and 37%, respectively, though precise figures remain challenging to ascertain.
• Sarcopenia significantly impacts IBD patient outcomes, including quality of life, prognosis, and response to treatments like surgery and medications.

Purpose of the Study:

• To review the current literature on the impact of sarcopenia in the management of IBD.
• To explore the mechanistic drivers, assessment methods, and management strategies for sarcopenia in IBD patients.

Main Methods:

• Literature review of existing studies on sarcopenia and IBD.
• Analysis of mechanistic pathways linking IBD, malnutrition, and sarcopenia.
• Evaluation of current diagnostic and therapeutic approaches.

Main Results:

• Sarcopenia is a significant factor influencing IBD patient management and outcomes.
• Research into counteracting sarcopenia is advancing in other chronic inflammatory conditions.
• Further investigation is needed to fully understand and manage sarcopenia in IBD.

Conclusions:

• Sarcopenia is a critical, underappreciated complication in IBD management.
• Understanding sarcopenia's role is essential for improving patient prognostication and treatment efficacy.
• Developing targeted interventions for sarcopenia in IBD is a priority for future research.